Evidence map›Paper›PMID 42612249›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2026

Cumulative Low-Level Viraemia Is Not Associated with Endothelial Function in Black African Adults With HIV.

Roland VAN Rensburg, Innocent Maposa, Camilla Pennefather, Chantel Schreuder, Lauren Jennings, Tracy Kellermann, Khethiwe Motha, Giovanni Schifitto, Catherine Orrell, Monica Gandhi and 2 more

Registry-linked trialAbstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05333679 (Urine Tenofovir Point-of-care Test to Identify Patients in Need of ART Adherence Support), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05333679 nacompletednot on this map

Urine Tenofovir Point-of-care Test to Identify Patients in Need of ART Adherence Support (UTRA Study)

TypeinterventionalSponsorUniversity of California, San FranciscoRan2022 to 2025Enrolled200ConditionsRisk ReductionArmsUTRA, UTRA feedback
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Roland VAN RensburgDivision of Clinical Pharmacology, Department of Medicine, Stellenbosch University, Cape Town, South Africa.ORCID 0000-0002-6464-4257
Innocent MaposaDivision of Epidemiology and Biostatistics, Department of Global Health, Stellenbosch University, Cape Town, South Africa.ORCID 0000-0002-3448-4096
Camilla PennefatherDivision of Clinical Pharmacology, Department of Medicine, Stellenbosch University, Cape Town, South Africa.ORCID 0000-0002-7845-4219
Chantel SchreuderDesmond Tutu Health Foundation and Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.ORCID 0009-0007-9456-3996
Lauren JenningsDesmond Tutu Health Foundation and Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.ORCID 0000-0003-4749-2404
Tracy KellermannDivision of Clinical Pharmacology, Department of Medicine, Stellenbosch University, Cape Town, South Africa.ORCID 0000-0003-1542-4976
Khethiwe MothaDivision of Clinical Pharmacology, Department of Medicine, Stellenbosch University, Cape Town, South Africa.ORCID 0000-0001-9003-851
Giovanni SchifittoDepartment of Neurology, University of Rochester, Rochester, New York, United States.ORCID 0000-0002-2115-4143
Catherine OrrellHIV and other Infectious Disease Unit, South African Medical Research Council, Cape Town, South Africa.ORCID 0000-0003-1134-7475
Monica GandhiDivision of HIV, Infectious Diseases, and Global Medicine, Department of Medicine, University of California, San Francisco, United States.ORCID 0000-0002-7025-1994
Gert VAN ZylDivision of Medical Virology, Department of Pathology, Stellenbosch University, Cape Town, South Africa.ORCID 0000-0003-3021-5101
Eric DecloedtDivision of Clinical Pharmacology, Department of Medicine, Stellenbosch University, Cape Town, South Africa.ORCID 0000-0003-1815-5150

Funding

Randomized Trial to Optimize Virologic Suppression Rates Using a Point-of-Care Urine Monitoring Assay (ROVING-PUMA)R01AI143340 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Monica Gandhi · 2018 to 2026
$5.6M
Urine tenofovir point-of-care test to identify patients in need of ART adherence supportR01AI152119 · NIAID · STELLENBOSCH UNIVERSITY · PI GANDHI, MONICA, ORRELL, CATHERINE · 2020 to 2024
$1.7M
University of Pittsburgh HIV-Comorbidities Research Training Program in South AfricaD43TW010937 · FIC · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI NACHEGA, JEAN BISIMWA, SEEDAT, SORAYA · 2019 to 2023
$1.2M
FIC NIH HHS D43 TW010937NIAID NIH HHS R01 AI143340NIAID NIH HHS R01 AI152119
6 · The paper itself

Abstract

backgroundPeople with HIV (PWH) experience excess cardiovascular disease (CVD) risk with persistent inflammation considered a key driver, despite antiretroviral therapy (ART). Low-level viraemia (LLV) may contribute to inflammation and vascular injury, but data in sub-Saharan Africa are limited. We assessed correlates of endothelial function among Black African PWH with a history of viraemia despite ART use.

methodsWe conducted a cross-sectional sub-study within the South African UTRA trial (NCT05333679). Endothelial function was measured with EndoPAT using the natural log-transformed reactive hyperaemia index (LnRHI); endothelial dysfunction was defined as LnRHI≤0.51. The primary exposure was 12-month cumulative HIV viral load (VL) area-under-the-curve (AUC). Body-mass index (BMI), waist-to-hip ratio (WHR), and body roundness index (BRI) were modelled using adjusted natural cubic splines with robust standard errors. We evaluated associations of various covariates, including these body composition metrics, with LnRHI via multivariable regression.

resultsOf 120 participants (median age 46 years, 69% women), 26% met criteria for endothelial dysfunction despite low 10-year CVD risk. Median LnRHI was 0.69 (IQR 0.50-0.94). Mean cumulative VL AUC was 1.55 log10 copy-years/mL (IQR 1.30-2.20), consistent with LLV. Cumulative VL was not associated with endothelial function after adjustment. In contrast, LnRHI varied significantly and non-linearly across BMI, WHR, and BRI, with an overall downward trend with increasing adiposity.

conclusionsIn this cross-sectional analysis of Black African PWH with LLV, no association between cumulative VL and endothelial dysfunction was observed. However, higher adiposity was consistently associated with declining endothelial function. Our data adds to the growing evidence on the importance of addressing body composition as a multifactorial risk determinant and important correlate of early vascular risk in PWH.

Indexed as

adiposityantiretroviral therapybody compositioncumulative viral loadEndothelial function

Identifiers

PMID42612249
PMCPMC13580889

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.